From: Prognostic value of inflammation-based indices in patients with resected hepatocellular carcinoma
Variables | Number of patients | co NLR-PDW 0 | co NLR-PDW 1 | co NLR-PDW 2 | P-value |
---|---|---|---|---|---|
Age, < 60/≥60 years | 194/56 | 31/11 | 108/35 | 55/10 | 0.281 |
Gender, male/female | 225/25 | 36/6 | 129/14 | 60/5 | 0.536 |
HBsAg, negative/positive | 29/221 | 5/37 | 17/126 | 7/58 | 0.971 |
Cirrhosis, no/yes | 79/171 | 21/21 | 42/99 | 16/44 | 0.004 |
Tumor size, ≤5/> 5 cm | 137/113 | 31/11 | 69/74 | 37/28 | 0.013 |
Tumor number, single/multiple | 179/71 | 32/10 | 99/44 | 48/17 | 0.609 |
AFP, < 400/≥400 ng/ml | 170/80 | 26/16 | 98/45 | 46/19 | 0.617 |
Vascular invasion, no/yes | 146/104 | 28/14 | 77/66 | 41/24 | 0.225 |
Child-Pugh grade, A/B | 235/15 | 41/1 | 137/6 | 57/8 | 0.041 |
BCLC, 0-A/ B-C | 19/79/48/104 | 23/19 | 50/93 | 25/40 | 0.069 |
Differentiation, well moderate/poor | 41/189/20 | 40/2 | 130/13 | 60/5 | 0.658 |
PT (s) | 13.6 (12.9–14.2) | 13.4 (12.7–14.1) | 13.6 (13.0–14.4) | 13.5 (13.1–14.2) | 0.143 |
ALT (U/L) | 38.0 (26.0–52.3) | 35.0 (22.5–46.5) | 40.0 (27.8–57.5) | 39.0 (26.0–50.0) | 0.093 |
TB (umol/L) | 14.7 (10.7–18.3) | 13.9 (9.8–16.0) | 14.3 (10.8–18.2) | 15.8 (12.4–20.5) | 0.032 |
GGT (U/L) | 60.5 (37.0–117.5) | 49.0 (26.0–98.0) | 64.5 (38.0–119.5) | 70.0 (43.0–135.0) | 0.055 |
ALB (g/L) | 40.0 ± 4.2 | 40.3 ± 3.7 | 39.5 ± 4.1 | 41.0 ± 4.6 | 0.053 |
MPV (Fl) | 10.6 (9.9–11.2) | 9.8 (9.4–10.2) | 10.6 (10.0–11.2) | 11.2 (10.8–11.6) | < 0.001 |